相关实验视频

Updated: Jul 18, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

发现PARP1抑制剂:采用机器学习和片段替代技术的创新选策略

Jiahui Tu¹, Jiaqi Chen², Nan Zhou²

¹The First Clinical College, Guangdong Medical University, Zhanjiang, 524023, China.

Molecular diversity

|June 11, 2025

概括

研究人员开发了一种机器学习管道,以发现新的PARP1抑制剂,其性能优于传统方法. 这种方法确定了有前途的候选药物,其活性和稳定性提高了癌症治疗的可能性.

科学领域:

在瘤学瘤学.
药用化学医学化学
计算生物学计算生物学

背景情况:

多 (ADP-ribose) 聚合酶1 (PARP1) 对于DNA修复和细胞应激至关重要.
PARP 抑制剂 (PARPi) 对BRCA1/2-突变癌症有效,但面临抗药性.
开发新的PARP1抑制剂对于克服治疗挑战至关重要.

研究的目的:

使用机器学习和虚拟选,创建一个高效的PARP1抑制剂发现管道.
为了识别具有优化类药物特性和高抑制活性的新型化合物.
通过分子对接和模拟来验证潜在的PARP1抑制剂.

主要方法:

集成机器学习模型 (随机森林) 与传统的虚拟选.
采用片段替代策略来产生新型化合物.
使用2D指纹,形状选,对接 (XP),ADMET预测和分子动力学 (MD) 模拟.

主要成果:

随机森林模型实现了高性能 (AUC=0.971,精度=0.915).
机器学习方法被证明比传统的虚拟选更有效.
与Talazoparib相比,确定了三种化合物,其对接得分优越,结合稳定性良好.

结论:

开发的管道有效地识别了强大的PARP1抑制剂.
发现了具有改善活性和类似药物的新化合物.
这些已识别的化合物代表了作为PARP1向癌症治疗药物进一步开发的有希望的候选者.

关键词:

在ADMET和分子动力学模拟 (MD模拟) 中.数据融合数据融合碎片替换是为了取代碎片.机器学习是机器学习.PARP1 的第一部分

更多相关视频

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

相关概念视频

Genetic Screens

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...